share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

諾瓦瓦克斯醫藥 | 4：持股變動聲明-董事 YOUNG JAMES F
美股SEC公告 ·  06/15 04:06
牛牛AI助理已提取核心訊息
James F. Young, associated with Novavax Inc [NVAX], completed a transaction on 06/12/2024 involving the acquisition of 6,670 shares of common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, directly increasing Young's holdings to a total of 76,760 shares of Novavax common stock.
James F. Young, associated with Novavax Inc [NVAX], completed a transaction on 06/12/2024 involving the acquisition of 6,670 shares of common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, directly increasing Young's holdings to a total of 76,760 shares of Novavax common stock.
諾瓦瓦克斯醫藥公司[NVAX]的詹姆斯•楊於2024年06月12日完成了一項交易，以零成本獲得6,670股普通股。此次交易被歸類爲衍生證券的行權或轉換，直接增加了楊的持股量，目前共持有76,760股諾瓦瓦克斯醫藥普通股。
諾瓦瓦克斯醫藥公司[NVAX]的詹姆斯•楊於2024年06月12日完成了一項交易，以零成本獲得6,670股普通股。此次交易被歸類爲衍生證券的行權或轉換，直接增加了楊的持股量，目前共持有76,760股諾瓦瓦克斯醫藥普通股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。